Language: BG BG
← Back to results
Active (not recruiting) Not applicable NCT03141437

Decision Aid Website in Helping to Make Decisions About Fertility in Participants With Cancer

No applicable phase (e.g. observational)
Conditions: Breast Neoplasm Colorectal Neoplasm Female Reproductive System Neoplasm Health Care Provider Lymphoma Plasma Cell Myeloma

Sponsor: M.D. Anderson Cancer Center

trial.available_in: БГ
Overview
This trial studies how well a decision aid website works in helping to make decisions about fertility in participants with cancer. Decision aid websites that provide information about fertility preservation (maintaining your ability to have children of your own after cancer treatment) may help participants with cancer make fertility-preservation decisions.
Description
PRIMARY OBJECTIVES: I. To assess the effect of the Pathways to Fertility patient decision aid website (DA website) with women of reproductive age seen at the MD Anderson Oncofertility Service, in terms of improving patients' decisional conflict. (Part 1) II. To assess the effect of a multicomponent oncofertility decision support intervention (multicomponent DS intervention) compared to usual care with women of reproductive age at selected MD Anderson Houston Area Locations (HALs) on patients' decisional conflict. (Part 2) SECONDARY OBJECTIVES: I. To assess patients' decision-making process (e.g., preparation for decision making, decision self-efficacy, satisfaction) and decision quality (e.g., fertility preservation knowledge, clarity of patients' values, and congruence of preferences with the decision and/or treatment received). (Part 1) II. To assess patients' decision-making process (e.g., preparation for decision making, decision self-efficacy, satisfaction) and decision quality (e.g., fertility preservation knowledge, clarity of patients' values, and congruence of preferences with the decision about whether to accept fertility preservation referral and/or fertility preservation treatment). (Part 2) EXPLORATORY OBJECTIVES: I. To explore the acceptability of the DA website (e.g., length, clarity, ease of use) and feasibility of the research methods (e.g., preferences for viewing at home versus at the clinic, timing of viewing, website usage, recommendations for improvement), in preparation for future planned dissemination and implementation studies. (Part 1) II. To explore the feasibility of the multicomponent DS intervention and research methods (e.g., clinician's perspectives of the educational session and referral process, website usage, rates of referrals, recommendations for improving the intervention and referral process) as delivered in the HALs oncology clinics, in preparation for future planned dissemination and implementation studies. (Part 2) OUTLINE: PART 1: Participants review decision aid website and complete questionnaires to help researchers learn the website's effect. PART 2: Participants are randomized into 1 of 2 arms. ARM I: Participants receive standard of care including education materials about fertility preservation from the Livestrong organization and a referral for fertility preservation, if requested. ARM II: Participants receive standard of care as in Arm I. Participants also use the decision-making the website.
Who can participate
Inclusion Criteria: * Newly diagnosed breast tumor, female genital system tumor, colorectal tumor, and/or lymphoma/myeloma * At risk for cancer-related infertility, as assessed by their clinician(s), including the oncofertility specialist * Must be able to speak, read, and write English * Must have internet access and a valid email address * Have not previously viewed the Pathways decision aid * For clinical provider participants: Clinical provider at a Houston Area Location of MD Anderson assigned to the intervention
Interventions
Best Practice
OTHER
Educational Intervention
OTHER
Internet-Based Intervention
OTHER
Questionnaire Administration
OTHER
Locations 1
United States (1)
M D Anderson Cancer Center
Houston , Texas
Technical details
Status
Active (not recruiting)
Phase
Not applicable
Study type
INTERVENTIONAL
Sex
Female only
Minimum age
18 Years
Maximum age
45 Years
Healthy volunteers
No
Start date
23.04.2017
Completion date
30.04.2027
Registry ID
NCT03141437
Source
clinicaltrials.gov
trial.inquiry_btn

Information is automatically extracted from ClinicalTrials.gov. Consult your doctor before taking action.